查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1570758

全球乳癌诊断市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Breast Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球乳癌诊断市场需求预计将从 2023 年的 52.2 亿美元达到近 104.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 8.05%。

乳癌诊断涉及一系列用于分阶段识别和评估乳癌的技术和工具。该领域结合了乳房X光摄影、超音波和MRI、活检程序和分子检测等影像方法，以实现准确的诊断和分期。这些诊断方法起到了检测作用，大大提高了治疗的前景和效果。现代诊断策略通常会结合多种技术来提高敏感性和特异性，使医疗保健提供者能够在正确的阶段发现肿瘤。该领域的最新进展包括用于精确三维成像的乳房断层合成以及用于检查循环肿瘤 DNA 以进行非侵入性癌症检测的液体活检。这种整体方法确保个人化治疗计划，最终导致患者的治疗结果和个人化医疗的进步。

市场动态

乳癌诊断市场是由多种因素推动的，包括乳癌发生率的增加、诊断技术的进步以及早期检测意识的提高。这种不断增加的负担凸显了对增强诊断工具和服务的需求。 MRI、数位乳房 X 光摄影和创新生物标记等技术进步正在改变诊断方式、改善早期检测并提高诊断准确性。例如，人工智慧在影像领域的发展正在显着提高乳癌检测的精度。西门子医疗 (Siemens Healthineers) 和通用电气医疗 (GE Healthcare) 等主要参与者正在整合人工智慧演算法，以支援放射科医生更准确、更有效率地识别异常情况。个人化医疗的日益普及进一步推动了市场机会，这需要先进的诊断工具来为个别患者提供个人化治疗。新一代定序技术和液体活检的实施正在为非侵入性监测和精确诊断创造新途径，从而扩大乳癌诊断市场。

医疗保健研发支出的不断增加也推动了市场的成长。例如，罗氏诊断公司最近推出了一种新的乳癌检测方法，利用先进的分子分析来指导治疗决策，代表着向精准和个人化医疗迈出的策略性倡议。此外，主要市场参与者之间的伙伴关係和协作正在推动创新。随着市场参与者继续在尖端研究和开发上投入资金，乳癌诊断市场预计将显着增长，新的诊断解决方案将增强早期检测和治疗选择。然而，先进诊断技术的高成本和资源匮乏环境中的取得机会有限阻碍了市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球乳癌诊断市场的每个细分市场进行了包容性评估。乳癌诊断产业的成长和趋势为这项研究提供了整体方法。

市场区隔

乳癌诊断市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

  • 影像学
  • 活检
  • 基因组测试
  • 血液检查
  • 其他的

按产品分类

  • 基于平台的产品（下一代定序、微阵列、PCR 等）
  • 以仪器为基础的产品（影像、切片）

按申请

  • 筛选
  • 诊断和预测
  • 预后
  • 研究

按最终用途

  • 医院和诊所
  • 诊断中心和医学实验室
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲乳癌诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。乳癌诊断市场的主要参与者包括 Hologic Inc.、Genomic Health (Exact Sciences Corporation)、BD、Danaher、Koninklijke Philips NV、QIAGEN、Thermo Fisher Scientific Inc.、Myriad Genetics Inc.、Argon Medical Devices Inc.、F霍夫曼-拉罗氏有限公司。 。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：乳癌诊断 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球乳癌诊断市场分析：按类型

  • 按类型概述
  • 按类型分类的历史和预测资料分析
  • 影像学
  • 活检
  • 基因组测试
  • 血液检查
  • 其他的

第 6 章：全球乳癌诊断市场分析：按产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 基于平台的产品（下一代定序、微阵列、PCR 等）
  • 以仪器为基础的产品（影像、切片）

第 7 章：全球乳癌诊断市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 筛选
  • 诊断和预测
  • 预后
  • 研究

第 8 章：全球乳癌诊断市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院和诊所
  • 诊断中心和医学实验室
  • 其他的

第 9 章：全球乳癌诊断市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：乳癌诊断公司的竞争格局

  • 乳癌诊断市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Hologic Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genomic Health (Exact Sciences Corporation)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BD
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Koninklijke Philips NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Myriad Genetics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Argon Medical Devices Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115626

The global demand for Breast Cancer Diagnostics Market is presumed to reach the market size of nearly USD 10.47 Billion by 2032 from USD 5.22 Billion in 2023 with a CAGR of 8.05% under the study period 2024-2032.

Breast cancer diagnostics involves a range of techniques and tools used to identify and evaluate breast cancer at phases. This area combines imaging methods, like mammography, ultrasound and MRI, biopsy procedures, and molecular testing to achieve accurate diagnosis and staging. These diagnostic methods play a role in detection, which greatly improves the outlook and effectiveness of treatment. Modern diagnostic strategies often merge techniques to improve sensitivity and specificity, allowing healthcare providers to spot tumors at the right stage. Recent advancements in this field include breast tomosynthesis for precise three-dimensional imaging and liquid biopsies that examine circulating tumor DNA for noninvasive cancer detection. This holistic approach ensures personalized treatment plans, ultimately leading to patient outcomes and progress in personalized medicine.

Market Dynamics

The breast cancer diagnostics market is driven by a combination of factors, including increasing incidence of breast cancer, advancements in diagnostic technology, and heightened awareness about early detection. This rising burden underscores the need for enhanced diagnostic tools and services. Technological advancements such as MRI, digital mammography, and innovative biomarkers are transforming diagnostics, improving early detection, and enhancing diagnostic accuracy. For instance, the development of AI in imaging is significantly propelling the precision of breast cancer detection. Key players like Siemens Healthineers & GE Healthcare are incorporating AI algorithms to support radiologists in identifying anomalies with greater accuracy and efficiency. Market opportunities are further propelled by the growing adoption of personalized medicine, which requires advanced diagnostic tools for personalized treatments for individual patients. The implementation of next-generation sequencing technologies and liquid biopsies is creating new avenues for noninvasive monitoring and precise diagnosis, thus expanding the breast cancer diagnostics market.

The escalating healthcare spending in research and development is also fuelling market growth. For instance, Roche Diagnostics has recently introduced a new breast cancer assay that leverages advanced molecular profiling to guide treatment decisions, representing a strategic move towards precision and personalized medicine. In addition, partnerships and collaborations among key market players are driving innovation. As market players continue to spend on cutting-edge research and development, the breast cancer diagnostics market is projected for significant growth, with new diagnostic solutions enhancing early detection and treatment options. However, high costs concerned with advanced diagnostic technologies and limited access in low-resource settings hamper market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Breast Cancer Diagnostics. The growth and trends of Breast Cancer Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Breast Cancer Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others

By Product

  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others)
  • Instrument-based Products (Imaging, Biopsy)

By Application

  • Screening
  • Diagnostic and Predictive
  • Prognostic
  • Research

By End-use

  • Hospitals & Clinics
  • Diagnostic Centers and Medical Laboratories
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Breast Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Breast Cancer Diagnostics market include Hologic Inc., Genomic Health (Exact Sciences Corporation), BD, Danaher, Koninklijke Philips N.V., QIAGEN, Thermo Fisher Scientific Inc., Myriad Genetics Inc., Argon Medical Devices Inc., F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BREAST CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Imaging Historic and Forecast Sales By Regions
  • 5.4. Biopsy Historic and Forecast Sales By Regions
  • 5.5. Genomic Tests Historic and Forecast Sales By Regions
  • 5.6. Blood Tests Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Historic and Forecast Sales By Regions
  • 6.4. Instrument-based Products (Imaging, Biopsy) Historic and Forecast Sales By Regions

7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Screening Historic and Forecast Sales By Regions
  • 7.4. Diagnostic and Predictive Historic and Forecast Sales By Regions
  • 7.5. Prognostic Historic and Forecast Sales By Regions
  • 7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 8.4. Diagnostic Centers and Medical Laboratories Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BREAST CANCER DIAGNOSTICS COMPANIES

  • 10.1. Breast Cancer Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF BREAST CANCER DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hologic Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Genomic Health (Exact Sciences Corporation)
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. BD
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Danaher
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Koninklijke Philips N.V.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. QIAGEN
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Thermo Fisher Scientific Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Myriad Genetics Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Argon Medical Devices Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. F. Hoffmann-La Roche Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Imaging Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Genomic Tests Market Sales By Geography (USD MN)
  • Blood Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Market Sales By Geography (USD MN)
  • Instrument-based Products (Imaging, Biopsy) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Screening Market Sales By Geography (USD MN)
  • Diagnostic and Predictive Market Sales By Geography (USD MN)
  • Prognostic Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers and Medical Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Breast Cancer Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Breast Cancer Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Breast Cancer Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Imaging Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Genomic Tests Market Sales By Geography (USD MN)
  • Blood Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Market Sales By Geography (USD MN)
  • Instrument-based Products (Imaging, Biopsy) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Screening Market Sales By Geography (USD MN)
  • Diagnostic and Predictive Market Sales By Geography (USD MN)
  • Prognostic Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers and Medical Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.